SL
CELG

Salomon & Ludwin’s Celgene Corp CELG Stock Holding History

Salomon & Ludwin’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-92
Closed -$9K – 250
2019
Q3 		$9K Hold
92
– – ﹤0.01% 174
2019
Q2 		$9K Sell
92
-18
-16% -$1.71K ﹤0.01% 169
2019
Q1 		$10K Buy
110
+18
+20% +$1.57K ﹤0.01% 165
2018
Q4 		$6K Buy
+92
New +$6.79K ﹤0.01% 171

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Salomon & Ludwin's CELG Position: Q4 2019 in Review

Salomon & Ludwin sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 92 shares — an estimated $9K sold.

Salomon & Ludwin first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $10K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Salomon & Ludwin reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Salomon & Ludwin sold 92 Celgene Corp shares in Q4 2019, an estimated $9K.
  • Salomon & Ludwin first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Salomon & Ludwin's Celgene Corp position peaked at $10K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Salomon & Ludwin's 13F filing for Q4 2019, filed 7 Feb 2020.